Emergent BioSolutions (EBS) Current Taxes (2017 - 2026)
Emergent BioSolutions has reported Current Taxes over the past 6 years, most recently at $7.2 million for Q1 2026.
- For Q1 2026, Current Taxes changed N/A year-over-year to $7.2 million; the TTM value through Mar 2026 reached $7.2 million, changed N/A, while the annual FY2025 figure was $6.8 million, 17.24% up from the prior year.
- Current Taxes for Q1 2026 was $7.2 million at Emergent BioSolutions, up from $6.8 million in the prior quarter.
- Over five years, Current Taxes peaked at $7.2 million in Q1 2026 and troughed at $5.8 million in Q4 2024.
- A 3-year average of $6.6 million and a median of $6.8 million in 2025 define the central range for Current Taxes.
- On a YoY basis, Current Taxes climbed as much as 17.24% in 2025 and fell as far as 17.24% in 2025.
- Year by year, Current Taxes stood at $5.8 million in 2024, then grew by 17.24% to $6.8 million in 2025, then increased by 5.88% to $7.2 million in 2026.
- Business Quant data shows Current Taxes for EBS at $7.2 million in Q1 2026, $6.8 million in Q4 2025, and $5.8 million in Q4 2024.